CVSIX
Price
$16.52
Change
+$0.02 (+0.12%)
Updated
Aug 21 closing price
Net Assets
18.6B
PSCAX
Price
$10.20
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Net Assets
403.42M
Interact to see
Advertisement

CVSIX vs PSCAX

CVSIX vs PSCAX Comparison Chart in %
View a ticker or compare two or three
VS
CVSIX vs. PSCAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVSIX is a StrongBuy and PSCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CVSIX has more cash in the bank: 18.6B vs. PSCAX (403M). PSCAX pays higher dividends than CVSIX: PSCAX (3.42) vs CVSIX (1.41). CVSIX was incepted earlier than PSCAX: CVSIX (36 years) vs PSCAX (14 years). PSCAX (2.31) is less costly to investors than CVSIX (1.26). PSCAX is a more actively managed with annual turnover of: 172.00 vs. CVSIX (43.00). CVSIX (2500) and PSCAX (2500) have matching initial minimum investment requirements. CVSIX annual gain was more profitable for investors over the last year : 6.49 vs. PSCAX (3.75). CVSIX return over 5 years is better than : 20.59 vs. PSCAX (9.99).
CVSIXPSCAXCVSIX / PSCAX
Total Expense Ratio1.261.6975%
Annual Report Gross Expense Ratio1.262.3155%
Fund Existence36 years14 years-
Gain YTD4.0543.643111%
Front Load3%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets18.6B403M4,615%
Annual Yield % from dividends1.413.4241%
Returns for 1 year6.493.75173%
Returns for 3 years17.8721.9082%
Returns for 5 years20.599.99206%
Returns for 10 years40.2936.90109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSOEX17.480.18
+1.04%
Nuveen International Res Eq Retire
TGCEX31.550.19
+0.61%
TCW Concentrated Large Cap Growth I Cl
OEGNX27.490.14
+0.51%
Invesco Discovery Mid Cap Growth R
DRISX23.100.11
+0.48%
North Square Small Cap Value I
PRBRX16.78N/A
N/A
Parnassus International Equity Investor